Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
Article has an altmetric score of 9

See more details

Referenced in 5 patents
46 readers on Mendeley
  • Article usage
  • Citations to this article (160)

Advertisement

Research Article Free access | 10.1172/JCI3338

Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation.

T F Choudhri, B L Hoh, H G Zerwes, C J Prestigiacomo, S C Kim, E S Connolly Jr, G Kottirsch, and D J Pinsky

College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA. djp5@columbia.edu

Find articles by Choudhri, T. in: JCI | PubMed | Google Scholar

College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA. djp5@columbia.edu

Find articles by Hoh, B. in: JCI | PubMed | Google Scholar

College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA. djp5@columbia.edu

Find articles by Zerwes, H. in: JCI | PubMed | Google Scholar

College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA. djp5@columbia.edu

Find articles by Prestigiacomo, C. in: JCI | PubMed | Google Scholar

College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA. djp5@columbia.edu

Find articles by Kim, S. in: JCI | PubMed | Google Scholar

College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA. djp5@columbia.edu

Find articles by Connolly, E. in: JCI | PubMed | Google Scholar

College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA. djp5@columbia.edu

Find articles by Kottirsch, G. in: JCI | PubMed | Google Scholar

College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA. djp5@columbia.edu

Find articles by Pinsky, D. in: JCI | PubMed | Google Scholar

Published October 1, 1998 - More info

Published in Volume 102, Issue 7 on October 1, 1998
J Clin Invest. 1998;102(7):1301–1310. https://doi.org/10.1172/JCI3338.
© 1998 The American Society for Clinical Investigation
Published October 1, 1998 - Version history
View PDF
Abstract

Treatment options in acute stroke are limited by a dearth of safe and effective regimens for recanalization of an occluded cerebrovascular tributary, as well as by the fact that patients present only after the occlusive event is established. We hypothesized that even if the site of major arterial occlusion is recanalized after stroke, microvascular thrombosis continues to occur at distal sites, reducing postischemic flow and contributing to ongoing neuronal death. To test this hypothesis, and to show that microvascular thrombosis occurs as an ongoing, dynamic process after the onset of stroke, we tested the effects of a potent antiplatelet agent given both before and after the onset of middle cerebral arterial (MCA) occlusion in a murine model of stroke. After 45 min of MCA occlusion and 23 h of reperfusion, fibrin accumulates in the ipsilateral cerebral hemisphere, based upon immunoblotting, and localizes to microvascular lumena, based upon immunostaining. In concordance with these data, there is a nearly threefold increase in the ipsilateral accumulation of 111In-labeled platelets in mice subjected to stroke compared with mice not subjected to stroke. When a novel inhibitor of the glycoprotein IIb/IIIa receptor (SDZ GPI 562) was administered immediately before MCA occlusion, platelet accumulation was reduced 48%, and fibrin accumulation was reduced by 47% by immunoblot densitometry. GPI 562 exhibited a dose-dependent reduction of cerebral infarct volumes measured by triphenyltetrazolium chloride staining, as well as improvement in postischemic cerebral blood flow, measured by laser doppler. GPI 562 caused a dose-dependent increase in tail vein bleeding time, but intracerebral hemorrhage (ICH) was not significantly increased at therapeutic doses; however, there was an increase in ICH at the highest doses tested. When given immediately after withdrawal of the MCA occluding suture, GPI 562 was shown to reduce cerebral infarct volumes by 70%. These data support the hypothesis that in ischemic regions of brain, microvascular thrombi continue to accumulate even after recanalization of the MCA, contributing to postischemic hypoperfusion and ongoing neuronal damage.

Version history
  • Version 1 (October 1, 1998): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

Article has an altmetric score of 9
  • Article usage
  • Citations to this article (160)

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 5 patents
46 readers on Mendeley
See more details